Showing results (21-30 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|December 6, 2021
Advances in polycythemia vera and lessons for acute leukemiaJerry L SpivakBest Practice & Research. Clinical Haematology|December 6, 2021
Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?Thai Hoa Tran, Sarah K TasianBest Practice & Research. Clinical Haematology|November 24, 2018
Progress and predictions: AML in 2018Jacob M RoweBest Practice & Research. Clinical Haematology|November 24, 2018
The role of hypomethylating agents prior to hematopoietic cell transplantation in myelodysplastic syndromesMikkael A SekeresBest Practice & Research. Clinical Haematology|November 24, 2018
Why and how to treat Ph-like ALL?Kathryn G RobertsBest Practice & Research. Clinical Haematology|November 24, 2018
Is the overall survival for older adults with AML finally improving?Jeffrey E LancetBest Practice & Research. Clinical Haematology|November 24, 2018
Which novel agents for acute myeloid leukemia are likely to change practice?Daniel A PollyeaBest Practice & Research. Clinical Haematology|November 24, 2018
Hematopoietic cell transplantation as treatment of patients with acute myeloid leukemia with measurable residual disease after consolidation therapyFrederick R AppelbaumBest Practice & Research. Clinical Haematology|April 1, 2019
Clonal Hematopoiesis and therapy related MDS/AMLPinkal Desai, Gail J RobozBest Practice & Research. Clinical Haematology|April 1, 2019
Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndromeChong Chyn Chua, Shaun Fleming, Andrew H WeiPageof 113